About us
Company overview
At the helm of US Pharma are visionaries Mr. Haresh Sanghvi and Mr. Tapan Sanghvi, whose combined experience drives our pursuit of excellence. From humble beginnings, US Pharma has rapidly ascended in the pharmaceutical landscape, boasting a remarkable trajectory of growth. What started as a venture producing 25 product types in 2016 has evolved into a powerhouse with over 700 in-house products today, with a robust pipeline promising even more.
Our manufacturing plant adheres to stringent international standards, certified by WHO GMP and GLP, ensuring the highest quality in every product we offer. Our dedicated teams, comprising experienced professionals, ensure prompt action and rigorous quality control at every step of the manufacturing process.
Our Expertise
US Pharma prides itself on a diverse portfolio, encompassing tablets, capsules, syrups, ointments, injectables, dermatologicals, parenterals, and suppositories. We are not only leading suppliers across Africa but also expanding our reach into CIS, Latin America, and beyond.
In our relentless pursuit of innovation, US Pharma boasts its own research and development facility, constantly striving to introduce new products to meet market demands. Our future expansion plans include the establishment of a new R&D center and nine additional manufacturing blocks, strategically dedicated to niche segments of the formulation basket.
Vision
Mission
- Establish and uphold rigorous standards of quality across every product.
- Strive for Best-in-Class practices in the formulation and manufacturing of each product.
- Implement a fair and efficient disciplinary system aligned with industry best practices.
- Provide a robust framework for continuous skill development for all our employees.
- Ensure timely delivery of every product with reliability.
- Partner with industry leaders and professional organizations that prioritize quality, timely delivery, and cost-effectiveness.
- Provide a robust framework for continuous skill development for all our employees.
- Ensure timely delivery of every product with reliability.
- Partner with industry leaders and professional organizations that prioritize quality, timely delivery, and cost-effectiveness.
Leadership
Tapan Haresh Sanghvi
Managing Director
Beginning his journey with the company in the finance domain, Tapan has seamlessly transitioned into pivotal roles in general administration and marketing, contributing significantly to the company’s growth and strategic direction.
Under his leadership, U. Pharma India has achieved milestones in pharmaceutical manufacturing, driven by a commitment to excellence and innovation. Tapan’s vision and strategic acumen have been instrumental in navigating the complexities of the industry, ensuring operational efficiency and sustainable growth.
Tapan continues to steer US Pharma India towards new horizons, guided by a passion for quality, integrity, and customer satisfaction.
Haresh Sanghvi
Founder
As a co-founder, Haresh spearheads project planning, product development, marketing strategies, and fosters a culture of innovation and excellence within the organization.
Key Managerial Personnels
Mr. Sanjay S. Trimbake
Regulatory Specialist
Armed with a science degree, Sanjay excels in navigating the regulatory landscapes of various regions, including Africa, the Middle East, SEA, and the Caribbean. He is adept at CTD/eCTD filing, obtaining registration certificates, and acquiring certifications from state licensing authorities.
Mr. Jainendra Singh
Business Development Specialist
With a sharp focus on African and Southeast Asian markets, Jainendra is well-versed in fostering relationships with existing and new partners. His keen knowledge of dosage forms makes him a valuable asset in driving business growth.
Mr. Shivudtt Dwivedi
Senior International Business Development Executive
Specializing in African, Middle Eastern, and Southeast Asian markets, Shivdutt excels in business development, partnering, and market expansion strategies. With comprehensive knowledge of international regulations and market dynamics, he drives successful collaborations and facilitates market penetration for pharmaceutical products.
Mr. Nilamadhav Sahu
Procurement Expert
Nilamadhav N. Sahu brings 7 years of expertise in procurement within the pharmaceutical industry.
As a Procurement Expert, Nilamadhav specializes in supplier negotiation and supply chain management. With a keen focus on quality and cost-effectiveness, he ensures the timely availability of high-quality pharmaceutical supplies, third-party finished products, and equipment.
Mr. Kamlesh Agaskar
Head of Export Department
With 29 years of rich experience in export of finished pharmaceutical products, Mr. Kamlesh Agaskar leads the Export Department at US Pharma.
Armed with a commerce degree, Kamlesh is an expert in handling DGFT, export documentation, and international shipping procedures. His meticulous attention to detail and effective communication skills ensure seamless export operations.
Mrs. Anjali S. Kalmate
Purchase Manager
Mrs. Anjali S. Kalmate manages the procurement of raw materials and packing materials at US Pharma.
Her expertise lies in developing vendor relationships, strategic purchasing, and ensuring timely procurement to meet business requirements.
Mr. Sandeep Panchal
Accounts Manager
Sandeep Panchal, the Accounts Manager at US Pharma, brings 17 years of experience in accounting within the pharmaceutical industry.
With a focus on budget forecasting, tax management, financial transactions, and compliance, Sandeep plays a pivotal role in ensuring financial stability and regulatory adherence.
Milestones
2014-2017: Tablets/Capsules/Liquid
- 2014: Acquisition of our first manufacturing facility.
- 2015: Initiated manufacturing with our first product, Metronidazole 250mg.
- 2016: Developed over 45 new products, expanding our portfolio significantly.
- 2017: Expanded manufacturing capabilities to include capsule production.
2018-2022: Ointment/Dry Syrup/Dry Powder/ Injectables/ Cephalosporins
- 2018: Successfully launched over 50 new products including New Mama Teno Foame and Scorpion Gel.
- 2019: Introduced Oral Suspension of ORS Dry Powder, catering to diverse medical needs.
- 2022: Developed an additional 80 products, marking a substantial growth milestone and expanded distribution across India.